Oct 9, 2024, 07:28
New findings on the Decipher genomic classifier – Prostate Cancer Foundation
Prostate Cancer Foundation shared a post on X:
”The Decipher genomic classifier is well-established in localized disease. A new analysis from STAMPEDE shows utility in metastatic prostate cancer as well.”
Source: Prostate Cancer Foundation/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 16, 2024, 11:27
Nov 16, 2024, 11:23
Nov 16, 2024, 11:17
Nov 16, 2024, 10:52
Nov 16, 2024, 10:44